相关临床试验
23
11 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
进行中（未招募）
10
43.5%
已完成
5
21.7%
尚未招募
1
4.3%
招募中
4
17.4%
终止
2
8.7%
撤回
1
4.3%
暂无批准数据
- A 53-year-old woman has been diagnosed with cancer for the third time in 15 years, now receiving lifelong Herceptin injections for stage four breast cancer. - Genetic testing after her second breast cancer revealed a CHEK2 mutation that can at least double lifetime breast cancer risk, according to Breast Cancer Trials. - After successful removal of a brain tumour, she requires Herceptin every three weeks and MRI scans every three months for the rest of her life. - She has raised £11,500 for the breast cancer ward at Russells Hall Hospital in Dudley and continues fundraising for the units that treated her.
- Breast Cancer Trials (BCT) is implementing a remote telehealth pre-screening process to broaden clinical trial access for regional and remote patients with molecularly targeted cancer treatments. - The process focuses on trials requiring specific molecular characteristics, utilizing circulating tumor DNA (ctDNA) blood tests and tissue samples tested at central laboratories. - Patients undergo telehealth consultations with BCT's Central Investigator for trial explanation and consent, with samples tested for trial-specific molecular targets before eligibility determination. - The initiative aims to improve trial participant diversity, enhance cancer outcomes, and strengthen research capacity while being piloted with the OLIO clinical trial.
- Australia's cancer clinical trials receive a $22.19 million funding boost to support 14 multi-site Collaborative Cancer Clinical Trials Groups (CTGs) nationwide. - The funding, administered by Cancer Australia, aims to improve clinical trial design, enhance equitable access, and accelerate research translation into clinical practice. - The program prioritizes addressing unmet needs, including rare cancers, and improving access to optimal cancer care, especially in rural and Indigenous communities. - The initiative aligns with the Australian Cancer Plan, focusing on reducing cancer's impact and improving outcomes through targeted and innovative research investment.
